Senior insider sale
Sr. VP and COO at Y-MABS THERAPEUTICS, INC. — senior position signals high conviction
$73.5K
5K shares
What this filing means
WILMS JORIS plans to sell 5K shares of Y-MABS THERAPEUTICS, INC. valued at approximately $73.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/26/2024ACC: 0001964306-24-000321
Officer· Sr. VP and COO
Since Sep 2018
5K
Shares to sell
$73.5K
Approx. market value
5K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
1/17/2024
5KTotal acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/17/2024 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 5K | — |
| Total | 5K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5K
Market value
$73.5K
8/26/2024
Total
Units
5K
Value
$73.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/26/2024 | 5K | $73.5K | NASDAQ | Planned |
| Total | 5K | $73.5K | ||